Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Starting on July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and Lilly CEO David Ricks has personally met with President Donald Trump in ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

Currently, 51 countries provide their citizens with some form of universal healthcare while Americans continue to struggle ...

A Tampa family celebrated their daughter's health milestone at the March of Dimes March for Babies walk. Lilly Lewellen spent ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Health officials are poised to announce trials to significantly widen access to the revolutionary injections. They will allow ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

Dr. Google is often on call for worried patients, but it may not give the best advice. Doctors say internet searches for ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...